Guillermo Izquierdo

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

Life Sciences, Immunology, Neurology +15

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

Veit Rothhammer, Iván Mascanfroni, Lukas Bunse et al. · Nature Medicine · 2016 · 1.5K citations · Full text

Life Sciences, Immunology, Neuroscience +17

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 547 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 438 citations · Full text

Life Sciences, Neurology, Neuroscience +8

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 416 citations · Full text

Life Sciences, Neurology, Neuroscience +12